Results 141 to 150 of about 36,254 (282)

E-Pharmacophore and virtual screening reveal Apium graveolens as a therapeutic prospect for vitiligo

open access: yesResults in Chemistry
Vitiligo is a skin depigmentation disorder resulting from an autoimmune response targeting melanocytes. A polygenic and multifactorial skin disease, which caused by association of oxidative stress, autoimmune, genetics, neurological system dysfunction ...
Femina Jamal Mohamed   +6 more
doaj   +1 more source

Identification of Potential Multitarget Compounds against Alzheimer's Disease through Pharmacophore-Based Virtual Screening. [PDF]

open access: yesPharmaceuticals (Basel), 2023
Mendes GO   +13 more
europepmc   +1 more source

Development of models for predicting Torsade de Pointes cardiac arrhythmias using perceptron neural networks

open access: yes, 2017
Blockage of some ion channels and in particular, the hERG cardiac potassium channel delays cardiac repolarization and can induce arrhythmia. In some cases it leads to a potentially life-threatening arrhythmia known as Torsade de Pointes (TdP).
Buzatu, Dan   +3 more
core   +1 more source

EGFR tyrosine kinase targeted compounds [PDF]

open access: yes, 2014
In this study, we illustrate computer aided drug design of new benzothiazole and pyrimido[2,1-b]benzothiazole derivatives as epidermal growth factor receptor tyrosine kinase (EGFR-TK) inhibitors.
El-Bendary, Eman R.   +3 more
core  

Structure-Based beta-Secretase (BACE1) Inhibitors [PDF]

open access: yes, 2014
Alois Alzheimer identified first abnormal deformation in the brain of diseased people with mental disorder. The disorder is clinically characterized by a progression from episodic memory problems to a slow global decline of cognitive function, ending ...
Keserű, György Miklós   +1 more
core  

Combinatorial Pharmacophore-Based 3D-QSAR Analysis and Virtual Screening of FGFR1 Inhibitors [PDF]

open access: gold, 2015
Nannan Zhou   +8 more
openalex   +1 more source

In silico study of structure-based screening of inhibitors to block PrPC conversion and amyloid aggregation

open access: yesFrontiers in Chemical Biology
Prion diseases are a group of progressive and fatal neurodegenerative diseases, caused by the transformation of cellular prion protein (PrPC) into a misfolded pathogenic isoform (PrPSc).
Kamakshi Ruhela   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy